"Research advances in ""treatment resistance"" of non-operative therapies for hepatocellular carcinoma" / 复旦学报(医学版)
Fudan University Journal of Medical Sciences
;
(6): 374-379,394, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-618383
ABSTRACT
Hepatocellular carcinoma (HCC) has the characteristics of high malignancy and poor prognosis.Liver transplantation and hepatectomy are applied in a small portion of patients with localized disease.Due to the hidden onset,HCC is usually diagnosed at an intermediate-advanced stage or with advancing cirrhosis.In most cases,various non-operative treatments are applied,including transarterial chemoembolization (TACE),local ablation,radiotherapy and molecular targeted drugs.The therapeutic effect of non-surgical treatments is not always ideal because the incidence of recurrence and metastasis after treatment is high.It also may be associated with treatment resistance of HCC to non-operative treatments.Optimizing the current management schemes has great significance in improving patients' quality of life and prolonging their survival.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Fudan University Journal of Medical Sciences
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS